US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

  • Biopharmaceuticals (255)
  • Diseases & Conditions (4037)
  • Drug Delivery (285)
  • Therapeutic Area (7265)
  • Vaccines (721)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

5  6  7  8    10    12  13  14  
Central Nervous System Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... worlds leading healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and ...  |  read more...
USD 1,495
Cardiovascular Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Lactic Acid Market by Application (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) & Polylactic Acid Market by Application (Packaging, Agriculture, Automobile, Electronics, Textile) & Geography - Global Trends & Forecasts to 2019
8/14/2014 | published by: MarketsandMarkets
... Lactic acid-based biodegradable polymers are projected to drive the demand for lactic acid across various industrial applications. The food & beverage segment is the second-largest application for lactic acid and will continue to drive the ...  |  read more...
USD 4,650
Personalized Medicine in Oncology Partnering Terms and Agreements
8/1/2014 | published by: Current Partnering
... by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter personalized medicine in oncology partnering deals. The majority of deals are discovery stage whereby the ...  |  read more...
USD 2,995
Trends in Therapeutic Partnering
8/1/2014 | published by: Current Partnering
... report provides a detailed understanding and analysis of the most popular therapeutic targets for partnering in the period 2009 to mid 2014. The majority of deals are discovery, preclinical and clinical stage whereby the licensee ...  |  read more...
USD 3,995
Calming and Sleeping - Saudi Arabia
8/8/2014 | published by: Euromonitor International
... impacted consumers’ health, resulting in insomnia and stress. These contributory factors thereby enabled calming and sleeping to see higher consumer demand in 2013, with current value growth of 15% in Saudi Arabia. Euromonitor International's Calming ...  |  read more...
USD 900
Calming and Sleeping - Spain
8/6/2014 | published by: Euromonitor International
... sales of these products, which are designed to contribute to wellbeing, at a time when sales of most OTC medicines were in decline. Euromonitor International's Calming and Sleeping in Spain report offers a comprehensive guide ...  |  read more...
USD 900
Cough, Cold and Allergy (Hay Fever) Remedies - Spain
8/6/2014 | published by: Euromonitor International
... change in prescription products that occurred in 2012, a number of drugs are now not dispensed by the Spanish health system, which led consumers to purchase these products in chemists/pharmacies. Euromonitor International's Cough, Cold and ...  |  read more...
USD 900
Digestive Remedies - Saudi Arabia
8/8/2014 | published by: Euromonitor International
... widespread culture of eating out is chiefly driven by the rising consumption of junk food. This therefore led consumers to move towards self-medication thanks to the growing advertising of digestive remedies. As a result, digestive ...  |  read more...
USD 900
Digestive Remedies - Spain
8/6/2014 | published by: Euromonitor International
... the government in order to reduce the public deficit. As such, the number of medicines that passed from being reimbursed to being OTC continued to expand during 2013, which directly benefited digestive remedies. Euromonitor International's ...  |  read more...
USD 900
Herbal/Traditional Products - Saudi Arabia
8/8/2014 | published by: Euromonitor International
... However, health-consciousness has started to gain ground amongst consumers and pharmacists. This therefore resulted in higher consumer demand for herbal/traditional products in 2013. As a result, herbal/traditional products registered value growth in current terms in ...  |  read more...
USD 900
Chemical & Pharmaceutical Plant Construction in Greece to 2018 : Market Databook
8/15/2014 | published by: Timetric
... chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the ...  |  read more...
USD 500
NRT Smoking Cessation Aids - Saudi Arabia
8/8/2014 | published by: Euromonitor International
... thanks to the fad of smoking shisha in Saudi Arabia. The government therefore started to introduce a smoking ban in 2011 in airports, and then in July 2012 in most public places and government offices. ...  |  read more...
USD 900
NRT Smoking Cessation Aids - Spain
8/6/2014 | published by: Euromonitor International
... interest in quitting smoking in 2013, which benefited sales of NRT smoking cessation aids in Spain, which grew by 1% to reach €24 million. Euromonitor International's NRT Smoking Cessation Aids in Spain report offers a ...  |  read more...
USD 900
Vitamins and Dietary Supplements - Spain
8/6/2014 | published by: Euromonitor International
... neighbouring European countries, as many Spaniards continued to be against the self-medication of vitamins. Euromonitor International's Vitamins and Dietary Supplements in Spain report offers a comprehensive guide to the size and shape of the market ...  |  read more...
USD 900
Cognosci, Inc. - Product Pipeline Review - 2014
8/14/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Cognosci, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Consumer Health Trends, Developments and Prospects
7/30/2014 | published by: Euromonitor International
... has consumers seeking products that support personal wellbeing. Attracted by bright growth prospects, companies are increasing stakes in consumer health. As policy updates shift regulations towards efficiency and product accessibility, the enforcement of consumer protection ...  |  read more...
USD 2,000
Arthritis - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Dyslipidemia - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... Dyslipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Inflammatory Pain - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Inflammatory Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Spinal Cord Injury - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Spinal Cord Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Duchenne Muscular Dystrophy - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Duchenne Muscular Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Migraine - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... Migraine, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Bladder Cancer - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Bladder Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Acute Pain - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Acute Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
5  6  7  8    10    12  13  14